The diagnostic and therapeutic challenge of early psoriatic arthritis

Dermatology

Volumn 221, Issue SUPPL. 1, 2010, Pages 6-14

  Gisondi, Paolo ^a,b   Tinazzi, Ilaria ^b   Del Giglio, Micol ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Psoriasis; Psoriasis, diagnosis; Psoriasis, therapy; Psoriatic arthritis

Indexed keywords

BONE EROSION; BONE SCINTISCANNING; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; ECHOGRAPHY; NAIL DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; SCALP PRURITUS; ARTHRITIS, PSORIATIC; HUMAN; MEDICAL ILLUSTRATION; PATHOLOGY; PROGNOSIS; PSORIASIS; RISK; SEVERITY OF ILLNESS INDEX;

ARTHRITIS, PSORIATIC; DIAGNOSTIC IMAGING; HUMANS; MEDICAL ILLUSTRATION; PROGNOSIS; PSORIASIS; RISK; SEVERITY OF ILLNESS INDEX;

EID: 77956021354     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316170     Document Type: Review

References (56)

1. Gladman DD: Psoriatic arthritis; in Harris ED Jr, Budd RC, Firestein GS, et al (eds): Kelley's Textbook of Rheumatology, ed 7. Philadelphia, Elsevier Saunders, 2005, vol 2, pp 1155-1164.
2. Dougados M, van der Linden S, Juhlin R, et al: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-1227.
3. McHugh NJ, Balachrishnan C, Jones SM: Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003; 42: 778-783.
4. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML: Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 1990; 17: 809-812.
5. Gladman DD, Farewell VT, Wong K, Husted J: Mortality studies in psoriatic arthritis: results from a single outpatient center. Prognostic indicators for death. Arthritis Rheum 1998; 41: 1103-1110.
6. Olivieri I, D'Angelo S, Padula A, Palazzi C: The challenge of early diagnosis of psoriatic arthritis. J Rheumatol 2008; 35: 3-5.
7. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM: Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a populationbased study. J Rheumatol 2009; 36: 361-367.
8. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D: Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005; 15: 279-283.
9. Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Junker P: The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis 2008; 67: 1422-1426.
10. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE: The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27: 1247-1250.
11. Wilson FC, Icen M, Crowson S, McEvoy MT, Gabriel SE, Kremers HM: Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61: 233-239.
12. Gelfand JM, Gladman DD, Mease PJ, et al: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
13. Pattison EJ, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN: Environmental risk factors for the development of psoriatic arthritis: results from a case control study. Ann Rheum Dis 2008; 67: 672-676.
14. McGonagle D, Tan AL, Benjamin M: The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann Rheum Dis 2008; 67: 1-4.
15. McHugh NJ, Laurent MR: The effect of pregnancy on the onset of psoriatic arthritis. Br J Rheumatol 1989; 28: 50-52.
16. Scarpa R, Del Puente A, di Girolamo C, della Valle G, Lubrano E, Oriente P: Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis 1992; 51: 78-79.
17. Serarslan G, Guler H, Karazincir S: The relationship between nail and distal phalangeal bone involvement severity in patients with psoriasis. Clin Rheumatol 2007; 26: 1245-1247.
18. Scarpa R, Soscia E, Peluso R, et al: Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 2006; 33: 1315-1319.
19. McGonagle D, Tan AL, Benjamin M: The nail as a musculoskeletal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218: 97-102.
20. Jajic I: Blue coloured skin in psoriatic arthritis. Clin Exp Rheumatol 2001; 19: 478.
21. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe H: Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992; 19: 1115-1119.
22. Brockbank JE, Stein M, Schentag CT, Gladman DD: Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005; 64: 188-190.
23. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT: Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 1993; 16: 1-7.
24. Kane D, Stafford L, Bresniham B, Fitzgerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-1468.
25. Queiro-Silva R, Torre-Alonso JC, Tinturé- Eguren T, López-Lagunas I: A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003; 62: 68-70.
26. Bond SJ, Farewell VT, Schentag CT, Gladman DD: Predictors for radiological damage in psoriatic arthritis. Results from a single centre. Ann Rheum Dis 2007; 66: 370-376.
27. Kavanaugh A, Antoni CE, Krueger GG, et al: Infliximab treatment dissociates the effect of CRP on radiographic progression in patients with psoriatic arthritis. Ann Rheum Dis 2007; 66(suppl II):417.
28. Gladman D, Mease PJ, Choy EH, et al: Analysis of risk factors for radiographic progression in psoriatic arthritis (PsA): subanalysis of ADEPT. Arthritis Rheum 2007; 56(suppl 9):S257.
29. Husted J, Gladman DD, Long JA, Farewell VT, Cook R: Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol 1997; 24: 511-517.
30. Sokoll KB, Helliwell PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001; 28: 1842-1846.
31. Husted JA, Tom BD, Farewell VT, Schentag CT, Gladman DD: A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007; 56: 840-849.
32. Olivieri I, de Portu S, Salvarani C, et al: The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. PACE working group. Rheumatology (Oxford) 2008; 47: 1664-1670.
33. Wong K, Gladman DD, Husted J, Long J, Farewell VT: Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and causes of death. Arthritis Rheum 1997; 40: 1868-1872.
34. Ali Y, Tom BDM, Schentag CT, Farewell VT, Gladman DD: Improved survival in psoriatic arthritis (PsA) with calendar time. Arthritis Rheum 2007; 56: 2708-2714.
35. Moll JM, Wright V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.
36. Taylor WJ, Gladman DD, Helliwell PS, et al: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
37. Chandran V, Schentag CT, Gladman DD: Sensitivity of the Classification of Psoriatic Arthritis (CASPAR) criteria in early psoriatic arthritis. Arthritis Rheum 2007; 57: 1560-1563.
38. Chandran V, Schentag CT, Gladman DD: Are the CASPAR criteria for psoriatic arthritis accurate when applied to patients attending a family practice clinic? Arthritis Rheum 2006; 54: 4091.
39. Peloso PM, Behl M, Hull P, Reeder B: The psoriasis & arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum 1997; 40(suppl 9): S64.
40. Alenius GM, Stenberg B, Stenlund H, Lundblad M, Dahlqvist SR: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of psoriatic and arthritic questionnaire. J Rheumatol 2002; 29: 2577-2582.
41. Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA: The PASE questionnaire: pilottesting a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007; 57: 581-587.
42. Gladman DD, Schentag CT, Tom BD, et al: Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009; 68: 497-501.
43. Wiell C, Szkudlarek M, Hasselquist M, et al: Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 2007; 9:R119.
44. Scarpa R, Cuocolo A, Peluso R, et al: Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2008; 35: 137-141.
45. Gisondi P, Tinazzi I, El-Dalati G, et al: Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital- based case-control study. Ann Rheum Dis 2008; 67: 26-30.
46. De Filippis LG, Caliri A, Lo Gullo R, et al: Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React 2005; 27: 159-162.
47. Ozcakar L, Cetin A, Inanici F, Kaymak B, Gurer CK, Kolemen F: Ultrasonographical evaluation of the Achilles' tendon in psoriasis patients. Int J Dermatol 2005; 44: 930-932.
48. De Simone C, Guerriero C, Giampetruzzi AR, Costantini M, Di Gregorio F, Amerio P: Achilles tendinitis in psoriasis: clinical and sonographic findings. J Am Acad Dermatol 2003; 49: 217-222.
49. Galluzzo E, Lischi DM, Taglione E, et al: Sonographic analysis of the ankle in patients with psoriatic arthritis. Scand J Rheumatol 2000; 29: 52-55.
50. Emery P: Evidence supporting the benefit of early intervention in rheumatoid arthritis. J Rheumatol 2002; 66(suppl):3-8.
51. Scarpa R, Peluso R, Atteno M, et al: The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol 2008; 27: 823-826.
52. Mease PJ, Kivitz AJ, Burch FX, et al: Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004; 50: 2264-2272.
53. Kavanaugh A, Antoni CE, Gladman D, et al: The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 2006; 65: 1038-1043.
54. Mease PJ, Gladman DD, Ritchlin CT, et al: Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52: 3279-3289.
55. Kavanaugh A, McInnes I, Mease P, et al: Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 2009; 60: 976-986.
56. Kavanaugh AF, Ritchlin CT; GRAPPA Treatment Guideline Committee: Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006; 33: 1417-1421.